DaShenLin Pharmaceutical Group Co., Ltd. (SHSE:603233) agreed to acquire 15% stake in Chongqing Wanjiayan Pharmacy Chain Co., Ltd from Chongqing Wanjiayan Health Industry Group Co., Ltd. and Bai Run for CNY 30 million on November 24, 2023. As of September 30, 2023, Chongqing Wanjiayan Pharmacy Chain Co., Ltd generated total assets of CNY 187 million and net assets of CNY 75.6 million.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
22.12 CNY | -3.24% | +1.56% | -11.16% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.16% | 3.49B | |
-34.16% | 14.83B | |
-22.89% | 12.04B | |
-25.00% | 6.52B | |
+14.96% | 6.44B | |
-9.27% | 6.15B | |
-2.92% | 4.63B | |
+60.00% | 4.62B | |
-8.10% | 3.93B | |
-6.69% | 3.05B |
- Stock Market
- Equities
- 603233 Stock
- News DaShenLin Pharmaceutical Group Co., Ltd.
- DaShenLin Pharmaceutical Group Co., Ltd. agreed to acquire 15% stake in Chongqing Wanjiayan Pharmacy Chain Co., Ltd from Chongqing Wanjiayan Health Industry Group Co., Ltd. and Bai Run for CNY 30 million.